Synthesis and SAR requirements of adamantane–colchicine conjugates with both microtubule depolymerizing and tubulin clustering activities

Bioorganic & Medicinal Chemistry
2011.0

Abstract

A series of analogues of conjugate 1, combining an adamantane-based paclitaxel (taxol) mimetic with colchicine was synthesized and tested for cytotoxicity in a cell-based assay with the human lung carcinoma cell line A549. The most active compounds (10 EC(50) 2 ± 1.0 nM, 23 EC(50) 6 ± 1.4 nM, 26 EC(50) 5 ± 1.8 nM, 28 EC(50) 11 ± 1.7 nM, 30 EC(50) 4.8 ± 0.5 nM) were found to interfere with the microtubule dynamics in an interesting manner. Treatment of the cells with these compounds promoted disassembly of microtubules followed by the formation of stable tubulin clusters. Structure-activity relationships for the analogues of 23 revealed the sensitivity of both cytotoxicity and tubulin clustering ability to the linker length. The presence of adamantane (or another bulky hydrophobic and non-aromatic moiety) in 23 was found to play an important role in the formation of tubulin clusters. Structural requirements for optimal activity have been partially explained by molecular modeling.

Knowledge Graph

Similar Paper

Synthesis and SAR requirements of adamantane–colchicine conjugates with both microtubule depolymerizing and tubulin clustering activities
Bioorganic & Medicinal Chemistry 2011.0
Design, synthesis, and bioactivity of putative tubulin ligands with adamantane core
Bioorganic & Medicinal Chemistry Letters 2008.0
Interactions of long-chain homologues of colchicine with tubulin
European Journal of Medicinal Chemistry 2017.0
Synthesis and biological evaluation of novel anticancer bivalent colchicine–tubulizine hybrids
Bioorganic & Medicinal Chemistry 2012.0
Synthesis of C2−C3‘N-Linked Macrocyclic Taxoids. Novel Docetaxel Analogues with High Tubulin Activity
Journal of Medicinal Chemistry 2004.0
Simple monocyclic pyrimidine analogs as microtubule targeting agents binding to the colchicine site
Bioorganic & Medicinal Chemistry 2023.0
Synthesis and biological evaluation of B-ring modified colchicine and isocolchicine analogs
Bioorganic & Medicinal Chemistry Letters 2006.0
Relationships between the structure of taxol analogs and their antimitotic activity
Journal of Medicinal Chemistry 1991.0
Biologically active taxol analogs with deleted A-ring side chain substituents and variable C-2' configurations
Journal of Medicinal Chemistry 1991.0
Antitumor agents. 139. Synthesis and biological evaluation of thiocolchicine analogs 5,6-dihydro-6(S)-acyloxy)- and 5,6-dihydro-6(S)-[(aroyloxy)methyl]-1,2,3-trimethoxy-9-(methylthio)-8H-cyclohepta[a]naphthalen-8-ones as novel cytotoxic and antimitotic agents
Journal of Medicinal Chemistry 1993.0